RHYTHM PHARMACEUTICALS INC (RYTM) Stock Income Statement
USA - NASDAQ:RYTM - US76243J1051 - Common Stock
99.86 USD
+2.23 (+2.28%)
36.0012 USD
-63.86 (-63.95%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 174.33M | 130.13M | 77.43M | 23.64M | 3.15M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 18.48M | 13.37M | 9.30M | 2.13M | 600.00K | |||
| Gross Profit | 155.86M | 116.76M | 68.13M | 21.51M | 2.56M | |||
| Operating Expenses | 342.06M | 382.26M | 252.48M | 200.67M | 172.61M | |||
| Research and Development | 166.48M | 237.96M | 134.95M | 108.63M | 104.13M | |||
| Selling, General, and Administrative Expenses | 175.59M | 144.30M | 117.53M | 92.03M | 68.49M | |||
| Operating Income | -186.21M | -265.50M | -184.36M | -179.16M | -170.06M | |||
| Interest Income/Expense | -6.69M | 3.01M | 53.00K | -1.17M | 450.00K | |||
| Other Income/Expense | 1.01M | 2.24M | 190.00K | -790.00K | 100.00M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -191.89M | -260.26M | -184.11M | -181.12M | -69.61M | |||
| Income Tax | 438.00K | 346.00K | 564.00K | null | 0 | |||
| Net Income | -197.71M | -264.57M | -184.68M | -181.12M | -69.61M | |||
| EBITDA | -184.76M | -263.94M | -182.60M | -177.49M | -168.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.1029999999999998 | -4.3376 | -3.2022 | -3.47 | -1.4 | |||
| Non GAAP EPS | -3.0999999999999996 | -4.49 | -3.1999999999999997 | -3.4800000000000004 | -3.41 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.40% | 89.73% | 87.99% | 90.99% | 81.27% | |||
| Profit Margin | -113.41% | -203.32% | -238.52% | -766.16% | -2209.84% | |||
| Operating Profit Margin | -106.81% | -204.04% | -238.10% | -757.87% | -5398.73% | |||
All data in USD